Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States

Publisher： Karger

E-ISSN： 1664-5553|6|3|216-226

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.3, 2017-04, pp. : 216-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of Local Hepatic Therapy to Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Stage BCLC C)

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

How to Improve Treatment Outcomes for Hepatocellular Carcinoma of Intermediate and Advanced Stage

By  

Digestive Diseases, Vol. 30, Iss. 6, 2012-12 ,pp. : 598-602

Karger

Access to resources Recommend Favorite

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment

By  

Liver Cancer, Vol. 5, Iss. 4, 2016-09 ,pp. : 257-268

Karger

Access to resources Recommend Favorite

Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis

By  

Digestion, Vol. 83, Iss. 4, 2011-02 ,pp. : 275-282

Karger

Access to resources Recommend Favorite

Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

By Ogasawara Sadahisa  

Hepatology International, Vol. 5, Iss. 3, 2011-09 ,pp. : 850-856

Springer Publishing Company

Access to resources Recommend Favorite